Earnest Partners LLC lowered its holdings in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 5.7% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 397,159 shares of the medical instruments supplier’s stock after selling 23,876 shares during the period. Earnest Partners LLC owned 0.17% of DENTSPLY SIRONA worth $26,145,000 as of its most recent filing with the SEC.
A number of other institutional investors have also bought and sold shares of XRAY. NuWave Investment Management LLC bought a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth approximately $121,000. Massey Quick Simon & CO. LLC bought a new stake in shares of DENTSPLY SIRONA during the third quarter worth approximately $124,000. Focused Wealth Management Inc boosted its holdings in shares of DENTSPLY SIRONA by 79.2% during the fourth quarter. Focused Wealth Management Inc now owns 2,600 shares of the medical instruments supplier’s stock worth $171,000 after acquiring an additional 1,149 shares during the period. First Interstate Bank bought a new stake in shares of DENTSPLY SIRONA during the third quarter worth approximately $164,000. Finally, Stock Yards Bank & Trust Co. bought a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth approximately $203,000. Institutional investors and hedge funds own 96.80% of the company’s stock.
In other news, Director Eric Brandt sold 6,409 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, January 8th. The shares were sold at an average price of $68.04, for a total value of $436,068.36. Following the completion of the sale, the director now directly owns 12,073 shares in the company, valued at $821,446.92. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 1.99% of the stock is currently owned by insiders.
Shares of DENTSPLY SIRONA Inc (NASDAQ XRAY) opened at $57.80 on Wednesday. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.12 and a quick ratio of 1.46. DENTSPLY SIRONA Inc has a 1 year low of $52.53 and a 1 year high of $68.98. The firm has a market cap of $13,418.07, a P/E ratio of 21.96, a PEG ratio of 2.55 and a beta of 1.21.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, March 1st. The medical instruments supplier reported $0.82 earnings per share for the quarter, beating analysts’ consensus estimates of $0.81 by $0.01. DENTSPLY SIRONA had a negative net margin of 39.39% and a positive return on equity of 8.35%. The company had revenue of $1.09 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the previous year, the business earned $0.67 earnings per share. The firm’s quarterly revenue was up 9.5% on a year-over-year basis. analysts predict that DENTSPLY SIRONA Inc will post 2.74 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 13th. Stockholders of record on Thursday, March 29th will be given a $0.0875 dividend. The ex-dividend date is Wednesday, March 28th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.61%. DENTSPLY SIRONA’s payout ratio is -5.09%.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.